Ascendis Pharma (ASND1N) Ownership - Who Owns Ascendis Pharma?
Ascendis Pharma (ASND1N) Ownership Overview
- 0.02% Insiders
- 35.27% Mutual Funds
- 0.61% Other Institutional Investors
- 5.48% ETFs
- 58.62% Public Companies and Individual Investors
The ownership structure of Ascendis Pharma (MX:ASND1N) stock is a mix of institutional, retail, and individual investors. Approximately 41.36% of the company’s stock is owned by Institutional Investors, 0.02% is owned by Insiders, and 58.62% is owned by Public Companies and Individual Investors.
The ownership structure of Ascendis Pharma (MX:ASND1N) stock is a mix of institutional, retail, and individual investors. Approximately 41.36% of the company’s stock is owned by Institutional Investors, 0.02% is owned by Insiders, and 58.62% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Sep 08, 2026 | Mads Bodenhoff | $810,570 | |
| Sep 02, 2026 | Lars Holtug | $62,332 | |
| Aug 17, 2026 | Jean Jacques Bienaime | $492,654 | |
| Jun 01, 2026 | Scott Thomas Smith | $21,900 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Peter Kolchinsky | 10,281,496 | Institution | 16.48% | 2,279,047,811 |
| T. Rowe Price Capital Appreciation Fund, Inc. | 3,364,767 | Institution | 5.39% | 745,851,077 |
| BlackRock, Inc. | 2,211,833 | Institution | 3.55% | 490,285,962 |
| Janus Investment Fund | 1,570,834 | Institution | 2.52% | 348,198,919 |
| Ishares | 1,429,399 | Institution | 2.29% | 316,847,729 |
| Mfs Series Trust Iv | 1,273,836 | Institution | 2.04% | 282,364,857 |
| Joseph Edelman | 1,163,721 | Institution | 1.87% | 257,956,215 |
| Vanguard Specialized Funds | 1,099,854 | Institution | 1.76% | 243,799,137 |
| Franklin Custodian Funds | 1,000,000 | Institution | 1.60% | 221,665,000 |
| Fidelity Select Portfolios | 998,701 | Institution | 1.60% | 221,377,057 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| T. Rowe Price Capital Appreciation Fund, Inc. | 3,364,767 | Institution | 5.39% | 745,851,077 |
| Janus Investment Fund | 1,570,834 | Institution | 2.52% | 348,198,919 |
| Mfs Series Trust Iv | 1,273,836 | Institution | 2.04% | 282,364,857 |
| Vanguard Specialized Funds | 1,099,854 | Institution | 1.76% | 243,799,137 |
| Franklin Custodian Funds | 1,000,000 | Institution | 1.60% | 221,665,000 |
| Fidelity Select Portfolios | 998,701 | Institution | 1.60% | 221,377,057 |
| Fidelity Securities Fund | 961,292 | Institution | 1.54% | 213,084,791 |
| Growth Fund Of America | 894,759 | Institution | 1.43% | 198,336,754 |
| Artisan Partners Funds Inc. | 676,607 | Institution | 1.08% | 149,980,091 |
| American Century Mutual Funds, Inc. | 664,000 | Institution | 1.06% | 147,185,560 |
FAQ
Who Owns Ascendis Pharma (MX:ASND1N)?
According to the latest TipRanks data, approximately 41.36% of the company's stock is held by institutional investors, 0.02% is held by insiders, and 58.62% is held by public companies and individual investors.
What percentage of Ascendis Pharma (MX:ASND1N) stock is held by institutional investors?
According to the latest TipRanks data, approximately 41.36% of Ascendis Pharma (MX:ASND1N) stock is held by institutional investors: 35.27% by mutual funds, 5.48% by ETFs and 0.61% by other institutional investors.
What percentage of Ascendis Pharma (MX:ASND1N) stock is held by retail investors?
According to the latest TipRanks data, approximately 58.62% of Ascendis Pharma (MX:ASND1N) stock is held by public companies and individual investors.
Who owns the most shares of Ascendis Pharma (MX:ASND1N)?
Peter Kolchinsky owns the most shares of Ascendis Pharma (MX:ASND1N).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
